Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001628280-16-020847
Filing Date
2016-11-04
Accepted
2016-11-04 15:01:55
Documents
83
Period of Report
2016-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q rtrx-20160930x10q.htm 10-Q 1230729
2 EXHIBIT 10.1 ex09302016101.htm EX-10.1 128298
3 EXHIBIT 10.2 ex09302016102.htm EX-10.2 98859
4 EXHIBIT 31.1 ex09302016311.htm EX-31.1 17371
5 EXHIBIT 31.2 ex09302016312.htm EX-31.2 17424
6 EXHIBIT 32.1 ex09302016321.htm EX-32.1 10365
7 EXHIBIT 32.2 ex09302016322.htm EX-32.2 10472
14 pipelinechartq2a01.jpg GRAPHIC 64587
  Complete submission text file 0001628280-16-020847.txt   6952802

Data Files

Seq Description Document Type Size
8 XBRL INSTANCE DOCUMENT rtrx-20160930.xml EX-101.INS 1338938
9 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT rtrx-20160930.xsd EX-101.SCH 54186
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT rtrx-20160930_cal.xml EX-101.CAL 105619
11 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT rtrx-20160930_def.xml EX-101.DEF 262638
12 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT rtrx-20160930_lab.xml EX-101.LAB 684085
13 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT rtrx-20160930_pre.xml EX-101.PRE 388202
Mailing Address 12255 EL CAMINO REAL SUITE 250 SAN DIEGO CA 92130
Business Address 12255 EL CAMINO REAL SUITE 250 SAN DIEGO CA 92130 212-983-1310
Retrophin, Inc. (Filer) CIK: 0001438533 (see all company filings)

EIN.: 262383102 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36257 | Film No.: 161974856
SIC: 2834 Pharmaceutical Preparations